COMPARING NEWER ORAL ANTI-PLATELETS PRASUGREL AND TICAGRELOR-A CUMULATIVE NETWORK META-ANALYSIS

The two newer antiplatelet drugs, prasugrel and ticagrelor have both been incorporated in various national guidelines and are both under consideration for approval or have already been approved by various drug regulatory authorities. However, superiority of any one remains controversial and